CUTANEOUS ANGIOSARCOMA
Clinical trials for CUTANEOUS ANGIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS ANGIOSARCOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus and immunotherapy team up against rare cancers
Disease control OngoingThis study tests whether combining a cancer-killing virus (T-VEC) with an immunotherapy drug (pembrolizumab) can shrink tumors in people with advanced sarcoma that cannot be removed by surgery. About 41 adults with certain sarcoma types will receive both drugs. The main goal is t…
Matched conditions: CUTANEOUS ANGIOSARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New combo therapy targets rare, aggressive skin cancer
Disease control OngoingThis study tests whether giving the chemotherapy drug paclitaxel before and during radiation therapy can help people with a rare and aggressive skin cancer called cutaneous angiosarcoma. The goal is to shrink the tumor before surgery and improve how long patients live without the…
Matched conditions: CUTANEOUS ANGIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 15, 2026 11:57 UTC